NCT00411801View on ClinicalTrials.gov

Safety and Efficacy Study to Compare Uniplas With Cryosupernatant Plasma in Thrombotic Thrombocytopenic Purpura (TTP)

PHASE3TerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Thrombotic Thrombocytopenic Purpura (TTP)
Interventions
BIOLOGICAL

Uniplas

Uniplas will be provided frozen in sterile plastic bags.

BIOLOGICAL

Cryosupernatant plasma

Cryosupernatant plasma will be provided frozen in sterile plastic bags.

Trial Locations (1)

20120

Contact Octapharma for Facility Details, Centreville

Sponsors

Lead Sponsor

Octapharma
All Listed Sponsors
lead

Octapharma

INDUSTRY